Eliyan Reaches $1 Billion Valuation With $145 Million Series C
The Santa Clara startup is building chiplet and licensing technology designed to move data faster between AI processors, memory and networking systems.
Archive
The Santa Clara startup is building chiplet and licensing technology designed to move data faster between AI processors, memory and networking systems.
The biotechnology company plans to move nonviral treatments for Duchenne muscular dystrophy and polycystic kidney disease toward clinical testing.
The Dublin, California semiconductor company plans to commercialize a component that moves power vertically toward high-performance processors.
The semiconductor startup is moving its co-packaged optics technology toward volume production as data centers demand faster, more efficient connections.